BCC Research Publishes a New Report On Global Markets for Flow Cytometry
The global market for flow cytometry products was valued at $3.1 billion in 2012 and is expected to reach nearly $3.5 billion in 2013. BCC Research projects the market to grow to nearly $5.7 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 10.3% from 2013 to 2018.
Wellesley, MA (PRWEB) November 04, 2013
According to a new technical market research report, Flow Cytometry: Products, Technologies and Global Markets from BCC Research (http://www.bccresearch.com), the global market for flow cytometry products was valued at $3.1 billion in 2012 and is expected to reach nearly $3.5 billion in 2013. BCC Research projects the market to grow to nearly $5.7 billion by 2018, and register a five-year compound annual growth rate (CAGR) of 10.3% from 2013 to 2018.
Increasing research and commercialization in various life science fields, such as proteomics, genomics, pharmacogenomics and stem cell research, have led to increased demand for high-throughput technologies such as flow cytometry. The introduction of multicolor flow cytometers with multiple lasers capable of simultaneously detecting up to 18 cell parameters is also exerting a strong impact on market growth.
Flow cytometry is a technology used to measure and analyze multiple characteristics of cells through a beam of light while they are in fluid suspension. Several properties related to cellular structure and cellular functions can be analyzed through this technique by either labeling or without labeling cells. Factors that can be analyzed include cell size, cell cycle, cell viability, enzymatic activities, membrane potentials, cellular antigens, DNA/RNA, protein synthesis, surface receptors, and more.
The expansion of flow cytometry applications from cellular analysis to molecular and genomic analysis has allowed flow cytometry technology to move beyond a basic research tool and emerge as a tool that plays an essential role in all phases of drug discovery. This includes testing new molecular entities (NMEs), identifying target molecules, lead characterization, biochemical screening, cell-based evaluation of hits, drug toxicity possibility, and drug efficacy. Additionally, flow cytometry is being used extensively in pharmacodynamic studies for some specific areas such as oncology and immunology.
The expansion of flow cytometry applications from cellular analysis to molecular and genomic analysis, increasing R&D spending, and a shift in small-molecule drug discovery will drive growth in this market over the near term.
This report from BCC Research provides an overview of the flow cytometry market. It analyzes global market trends, with data from 2012, estimates for 2013, and projections of CAGRs through 2018. This study also breakdowns the flow cytometry market into segments such as instruments, reagents, software, services, technologies, applications, and end users. Growth constraints such as increased equipment costs also find a mention in the report. In addition, this study presents comprehensive company profiles of major players in the industry.
This study is primarily intended for R&D directors, CEOs, and marketing managers of flow cytometry and allied technology manufacturers and service providers. The study will enable the audience to understand the changing market scenario and acceptance levels of the technology. It will also be useful to decision-makers in the life sciences industry who can utilize the data to understand the benefits and restraints of flow cytometry technologies.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/11/prweb11294423.htm